University of Michigan > Medical System > Center for Gene Therapy > The Vector Core

  


 
 
 

 

Note: As of 9/19/01, the NGVL plasmids have been renamed as UMVC plasmids to reflect the completion of the NGVL program at the University of Michigan.  The plasmids are still available to all investigators at the same price, but the reference name has changed.  If you have any questions please contact the lab supervisor at lanigant@umich.edu .

Viral Vector Maximum Insert Size Preferential Target Cells Common Research Applications General Advantages
Adenovirus 7.5 kb Transduces cells with CAR & avB integrinsreceptors very well

Will transiently transduce many primary cells at high effeciency

In vitro and in vivo transgene expression

siRNA

Ease of use in vitro and in vivo

High titiers

Adeno-Associated Virus (AAV) 3.5 kb Transfects wide variety of cell types, including muscle, nervous, liver, skin, and eye Non-immunogenic and thus practical for in vivo applications

Transgene expression has been shown to persist for over a year

Been used successfully in gene therapy trials for hemophilia in pre-clinical animal studies
No viral genes present or expressed

Non-pathogenic to humans

Can deliver transgenes to dividing and non-dividing cells

Long-term transgene expression
Lentivirus (FIV) > 8 kb Will transduce (via integration) differentiated non-dividing cells including Hematopoietic and Nervous, as well as dividing cells such as liver and skin Stable integration allows for both production of permanent cell lines for in vitro applications and long-term modifications for in vivo and ex vivo applications Transfects dividing and non-dividing cells

Integration into genome

Wide spectrum of target cells
Retrovirus (MoMLV) > 8 kb Transfects and integrates into wide variety of dividing cells Stable integration allows for both production of permanent cell lines for in vitro applications and long-term modifications for in vivo and ex vivo applications Integration into genome

Wide spectrum of target cells